SciELO - Scientific Electronic Library Online

 
vol.50 número2Comparación de la detección foto óptica vs. electromecánica del coáguloDetección de inhibidor adquirido específico de factor VIII índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

Compartir


Acta bioquímica clínica latinoamericana

versión impresa ISSN 0325-2957versión On-line ISSN 1851-6114

Resumen

LAURICELLA, Ana María; SITTINGER, Katja; GEISEN, Christof  y  KORDICH, Lucía Clelia. “Dysfibrinogenemia Jujuy”, associated to bleeding Disorders. Acta bioquím. clín. latinoam. [online]. 2016, vol.50, n.2, pp.215-221. ISSN 0325-2957.

The aim of this work was to study a young female with moderate bleeding symptoms, to characterize the plasma fibrin and to identify the possible molecular alteration in the fibrinogen of the patient and her family. A dysfibrinogenemia was diagnosed in the patient, the mother and the half-brother, both the latter asymptomatic. Kinetic parameters obtained from fibrin formation and lysis assays of the patient’s plasma samples were significantly different compared to the ones obtained with control plasma. A prolonged lag phase  indicated slow and defective fibrinopeptide releases, whereas a minor slope suggested an impaired fibrin assembly. A lower ODMax revealed a fibrin network composed of thinner fibers. Fibrinolysis induced by streptokinase resulted faster than control. DNA sequencing showed a homozygous deletion leading to AaGly14del (according to http://www.geht.org/databaseang/fibrinogen). The mother and the half-brother resulted heterozygous for the same mutation. This previously undescribed alteration was named fibrinogen Jujuy. The mutate fibrinogen might not be correctly fixed to the active site of thrombin resulting in slow cleavage and release of fibrinopeptides, rendering thinner fibers, more susceptible to lysis than control. This mechanism may explain the moderate bleeding symptoms of the patient.

Palabras clave : Dysfibrinogenemia; Coagulation tests; Fibrin formation; Fibrin lysability.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons